Publisher Correction: TGF-β blockade drives a transitional effector phenotype in T cells reversing SIV latency and decreasing SIV reservoirs in vivo

Jinhee Kim¹, Deepanwita Bose^#², Mariluz Araínga^#², Muhammad R Haque³, Christine M Fennessey⁴, Rachel A Caddell⁵, Yanique Thomas³, Douglas E Ferrell², Syed Ali², Emanuelle Grody^{3

6}, Yogesh Goyal^{3

6

7}, Claudia Cicala⁸, James Arthos⁸, Brandon F Keele⁴, Monica Vaccari^{5

9}, Ramon Lorenzo-Redondo^{1

10}, Thomas J Hope³, Francois Villinger², Elena Martinelli¹¹

Affiliations

¹ Department of Medicine, Division of Infectious Diseases, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
² New Iberia Research Center, University of Louisiana at Lafayette, New Iberia, LA, USA.
³ Cell and Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
⁴ AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
⁵ Division of Immunology, Tulane National Primate Research Center, Covington, LA, USA.
⁶ Center for Synthetic Biology, Northwestern University, Chicago, IL, USA.
⁷ Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
⁸ Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
⁹ Department of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA, USA.
¹⁰ Center for Pathogen Genomics and Microbial Evolution, Northwestern University Havey Institute for Global Health, Chicago, IL, USA.
¹¹ Department of Medicine, Division of Infectious Diseases, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. elena.martinelli@northwestern.edu.

^# Contributed equally.

Published Erratum

Jinhee Kim et al. Nat Commun. 2024.

. 2024 Oct 10;15(1):8787.

doi: 10.1038/s41467-024-52897-z.

¹ Department of Medicine, Division of Infectious Diseases, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
² New Iberia Research Center, University of Louisiana at Lafayette, New Iberia, LA, USA.
³ Cell and Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
⁴ AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
⁵ Division of Immunology, Tulane National Primate Research Center, Covington, LA, USA.
⁶ Center for Synthetic Biology, Northwestern University, Chicago, IL, USA.
⁷ Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
⁸ Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
⁹ Department of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA, USA.
¹⁰ Center for Pathogen Genomics and Microbial Evolution, Northwestern University Havey Institute for Global Health, Chicago, IL, USA.
¹¹ Department of Medicine, Division of Infectious Diseases, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. elena.martinelli@northwestern.edu.

^# Contributed equally.

No abstract available

Erratum for

TGF-β blockade drives a transitional effector phenotype in T cells reversing SIV latency and decreasing SIV reservoirs in vivo.
Kim J, Bose D, Araínga M, Haque MR, Fennessey CM, Caddell RA, Thomas Y, Ferrell DE, Ali S, Grody E, Goyal Y, Cicala C, Arthos J, Keele BF, Vaccari M, Lorenzo-Redondo R, Hope TJ, Villinger F, Martinelli E. Kim J, et al. Nat Commun. 2024 Feb 14;15(1):1348. doi: 10.1038/s41467-024-45555-x. Nat Commun. 2024. PMID: 38355731 Free PMC article.